AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$31.11
+0.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 92.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.18x
- Price / sales
- —
- Price / cash flow
- -10.37x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- —
- EV / EBITDA
- -7.09x
- EV / EBIT
- -6.60x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026